Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/24/2008
 
Trade Name:  Depakote ER Depakote Sprinkles
 
Generic Name or Proper Name (*):  divalproex disodium
 
Indications Studied:  Pediatric Bipolar Disorder; Prophylaxis of Migraine
 
Label Changes Summary:  Efficacy was not established in a double-blind, placebo controlled study of patients 10-17 years conducted to evaluate efficacy in the treatment of pediatric bipolar disorder Efficacy was not established in a double-blind, placebo-controlled study of patients 12  17 years conducted to evaluate the efficacy in the prophylaxis of migraine The safety and tolerability was similar to adults in 5 long-term safety studies Additional information on clinical studies, AE profile in Depakote ER labeling
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  Abbott
 
Pediatric Exclusivity Granted Date:  12/14/2007
 
NNPS:  FALSE'
 
Therapeutic Category:  Anticonvulsant; Mood Stablizer
 
-
-